These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15037864)

  • 1. Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review.
    Smits KM; Smits LJ; Schouten JS; Stelma FF; Nelemans P; Prins MH
    Mol Psychiatry; 2004 May; 9(5):433-41. PubMed ID: 15037864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders.
    Serretti A; Cusin C; Rossini D; Artioli P; Dotoli D; Zanardi R
    Am J Med Genet B Neuropsychiatr Genet; 2004 Aug; 129B(1):36-40. PubMed ID: 15274037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients.
    Smits KM; Smits LJ; Peeters FP; Schouten JS; Janssen RG; Smeets HJ; van Os J; Prins MH
    Psychiatr Genet; 2008 Aug; 18(4):184-90. PubMed ID: 18628680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response.
    Min W; Li T; Ma X; Li Z; Yu T; Gao D; Zhang B; Yun Y; Sun X
    Psychopharmacology (Berl); 2009 Aug; 205(3):409-17. PubMed ID: 19468717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
    Kim H; Lim SW; Kim S; Kim JW; Chang YH; Carroll BJ; Kim DK
    JAMA; 2006 Oct; 296(13):1609-18. PubMed ID: 17018806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism.
    Kato M; Ikenaga Y; Wakeno M; Okugawa G; Nobuhara K; Fukuda T; Fukuda K; Azuma J; Kinoshita T
    Int Clin Psychopharmacol; 2005 May; 20(3):151-6. PubMed ID: 15812265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments.
    Serretti A; Benedetti F; Zanardi R; Smeraldi E
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1074-84. PubMed ID: 15939518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of serotonin transporter and receptor gene polymorphisms in treatment response to selective serotonin reuptake inhibitors in major depressive disorder.
    Ramesh V; Venkatesan V; Ramasamy B
    Hum Psychopharmacol; 2022 Jul; 37(4):e2830. PubMed ID: 34994008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin transporter gene polymorphism and antidepressant response.
    Kim DK; Lim SW; Lee S; Sohn SE; Kim S; Hahn CG; Carroll BJ
    Neuroreport; 2000 Jan; 11(1):215-9. PubMed ID: 10683861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of a role for the 5-HTTLPR genotype in the modulation of motor response to antidepressant treatment.
    Putzhammer A; Schoeler A; Rohrmeier T; Sand P; Hajak G; Eichhammer P
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):303-8. PubMed ID: 15322730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine.
    Ito K; Yoshida K; Sato K; Takahashi H; Kamata M; Higuchi H; Shimizu T; Itoh K; Inoue K; Tezuka T; Suzuki T; Ohkubo T; Sugawara K; Otani K
    Psychiatry Res; 2002 Aug; 111(2-3):235-9. PubMed ID: 12374640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.
    Murphy GM; Hollander SB; Rodrigues HE; Kremer C; Schatzberg AF
    Arch Gen Psychiatry; 2004 Nov; 61(11):1163-9. PubMed ID: 15520364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI).
    Eichhammer P; Langguth B; Wiegand R; Kharraz A; Frick U; Hajak G
    Psychopharmacology (Berl); 2003 Mar; 166(3):294-7. PubMed ID: 12563545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders.
    Yu YW; Tsai SJ; Chen TJ; Lin CH; Hong CJ
    Mol Psychiatry; 2002; 7(10):1115-9. PubMed ID: 12476327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin transporter polymorphisms and the occurrence of adverse events during treatment with selective serotonin reuptake inhibitors.
    Smits K; Smits L; Peeters F; Schouten J; Janssen R; Smeets H; van Os J; Prins M
    Int Clin Psychopharmacol; 2007 May; 22(3):137-43. PubMed ID: 17414739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin Transporter Gene Polymorphisms and Selective Serotonin Reuptake Inhibitor Tolerability: Review of Pharmacogenetic Evidence.
    Zhu J; Klein-Fedyshin M; Stevenson JM
    Pharmacotherapy; 2017 Sep; 37(9):1089-1104. PubMed ID: 28654193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin transporter gene polymorphisms may be associated with poststroke neurological recovery after escitalopram use.
    Lee EJ; Oh MS; Kim JS; Chang DI; Park JH; Cha JK; Heo JH; Sohn SI; Kim DE; Kim HY; Kim J; Seo WK; Lee J; Park SW; Kim YJ; Lee BC;
    J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):271-276. PubMed ID: 29030421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms of serotonin and dopamine transporters in mental disorders.
    Ueno S
    J Med Invest; 2003 Feb; 50(1-2):25-31. PubMed ID: 12630565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of selective serotonin reuptake inhibitor response: a 6-month follow-up.
    Serretti A; Zanardi R; Franchini L; Artioli P; Dotoli D; Pirovano A; Smeraldi E
    Pharmacogenetics; 2004 Sep; 14(9):607-13. PubMed ID: 15475734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism of the serotonin transporter: implications for the use of selective serotonin reuptake inhibitors.
    Lotrich FE; Pollock BG; Ferrell RE
    Am J Pharmacogenomics; 2001; 1(3):153-64. PubMed ID: 12083964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.